Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC) Meeting Abstract

  


Authors: Tagawa, S. T.; Saran, A.; Akhtar, N. H.; Goel, S.; Mileo, G.; Kung, S.; Beltran, H.; Milowsky, M. I.; Mazumdar, M.; Wright, J. J.; Nanus, D. M.; New York Cancer Consortium
Abstract Title: Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880304066
DOI: 10.1200/jco.2011.29.15_suppl.e15165
PROVIDER: wos
Notes: Meeting Abstract: e15165 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Madhu Mazumdar
    127 Mazumdar
  2. Matthew I Milowsky
    76 Milowsky
Related MSK Work